| Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice F Piccioni, M Malvicini, MG Garcia, A Rodriguez, C Atorrasagasti, ... Glycobiology 22 (3), 400-410, 2012 | 120 | 2012 |
| A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets J Bayo, EJ Fiore, LM Dominguez, A Real, M Malvicini, M Rizzo, ... Journal of hepatology 71 (1), 78-90, 2019 | 94 | 2019 |
| Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice EJ Fiore, JM Bayo, MG Garcia, M Malvicini, R Lloyd, F Piccioni, M Rizzo, ... Stem cells and development 24 (6), 791-801, 2015 | 90 | 2015 |
| Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response L Alaniz, M Rizzo, M Malvicini, J Jaunarena, D Avella, C Atorrasagasti, ... Cancer letters 278 (1), 9-16, 2009 | 72 | 2009 |
| Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells C Atorrasagasti, M Malvicini, JB Aquino, L Alaniz, M Garcia, M Bolontrade, ... International journal of cancer 126 (11), 2726-2740, 2010 | 66 | 2010 |
| Adenovirus‐mediated inhibition of SPARC attenuates liver fibrosis in rats AM Camino, C Atorrasagasti, D Maccio, F Prada, E Salvatierra, M Rizzo, ... The journal of gene medicine 10 (9), 993-1004, 2008 | 65 | 2008 |
| Immunotherapy and immunoescape in colorectal cancer G Mazzolini, O Murillo, C Atorrasagasti, J Dubrot, I Tirapu, M Rizzo, ... World journal of gastroenterology: WJG 13 (44), 5822, 2007 | 65 | 2007 |
| Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice C Atorrasagasti, E Peixoto, JB Aquino, N Kippes, M Malvicini, L Alaniz, ... PloS one 8 (2), e54962, 2013 | 64 | 2013 |
| 4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis F Piccioni, E Fiore, J Bayo, C Atorrasagasti, E Peixoto, M Rizzo, ... Glycobiology 25 (8), 825-835, 2015 | 59 | 2015 |
| Trypanosoma cruzi: analysis of the complete PUF RNA-binding protein family F Caro, N Bercovich, C Atorrasagasti, MJ Levin, MP Vázquez Experimental parasitology 113 (2), 112-124, 2006 | 56 | 2006 |
| SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF C Atorrasagasti, JB Aquino, L Hofman, L Alaniz, M Malvicini, M Garcia, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 300 (5 …, 2011 | 55 | 2011 |
| 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T cell response induced by interleukin-12 MM Rodríguez, E Fiore, J Bayo, C Atorrasagasti, M García, A Onorato, ... Molecular Therapy 26 (12), 2738-2750, 2018 | 52 | 2018 |
| A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice M Malvicini, M Rizzo, L Alaniz, F Piñero, M García, C Atorrasagasti, ... Clinical Cancer Research 15 (23), 7256-7265, 2009 | 51 | 2009 |
| Significance of simple steatosis: an update on the clinical and molecular evidence G Mazzolini, JP Sowa, C Atorrasagasti, Ö Kücükoglu, WK Syn, A Canbay Cells 9 (11), 2458, 2020 | 50 | 2020 |
| SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice C Atorrasagasti, A Onorato, ML Gimeno, L Andreone, M Garcia, ... Clinical science 133 (2), 351-365, 2019 | 46 | 2019 |
| Immunotherapy for liver tumors: present status and future prospects P Matar, L Alaniz, V Rozados, JB Aquino, M Malvicini, C Atorrasagasti, ... Journal of biomedical science 16, 1-18, 2009 | 45 | 2009 |
| Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma L Alaniz, M Rizzo, MG Garcia, F Piccioni, JB Aquino, M Malvicini, ... Cancer Immunology, Immunotherapy 60, 1383-1395, 2011 | 37 | 2011 |
| Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12 M Malvicini, M Ingolotti, F Piccioni, M Garcia, J Bayo, C Atorrasagasti, ... Molecular Oncology 5 (3), 242-255, 2011 | 36 | 2011 |
| Unique features of the Trypanosoma cruzi U2AF35 splicing factor M Vázquez, C Atorrasagasti, N Bercovich, R Volcovich, MJ Levin Molecular and biochemical parasitology 128 (1), 77-81, 2003 | 35 | 2003 |
| SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage E Peixoto, C Atorrasagasti, JB Aquino, R Militello, J Bayo, E Fiore, ... Gene therapy 22 (1), 9-19, 2015 | 34 | 2015 |
